Skip to main content

Does Cabometyx (cabozantinib) cure cancer?

Medically reviewed by Philip Thornton, DipPharm. Last updated on Sep 18, 2023.

Official answer


Cabometyx (cabozantinib) does not cure cancer. It is a tyrosine kinase inhibitor that is approved to treat:

  • Advanced renal cell carcinoma (kidney cancer)
  • Advanced renal cell carcinoma, as a first-line treatment in combination with nivolumab (Opdivo)
  • Hepatocellular carcinoma (liver cancer) in people who have previously been treated with sorafenib (Nexavar)
  • Advanced or metastatic differentiated thyroid cancer that has progressed following VEGFR-targeted therapy in people who do not respond or are unable to take radioactive iodine

Cabometyx is used to delay the progression of cancer and increase the length of time a person with cancer survives for. How effective Cabometyx is at doing this depends on the type of cancer a person has and how advanced it is.

Patients on Cabometyx typically keep taking it until their cancer progresses or they have to stop because of side effects or adverse reactions.


Related medical questions

Drug information

Related support groups